Sale!

Breast Comprehensive Panel NGS Genetic Test

4,400 د.إ

-27%

The Breast Comprehensive Panel NGS (Next-Generation Sequencing) Genetic Test is a cutting-edge diagnostic tool offered by DNA Labs UAE, designed to provide an in-depth analysis of genetic mutations associated with breast cancer. Priced at 4400 AED, this comprehensive test screens for a wide array of genetic markers that are known to influence the risk of developing breast cancer. Utilizing the latest NGS technology, the panel can simultaneously analyze multiple genes to detect mutations with high accuracy and speed, enabling personalized risk assessment and guiding targeted treatment options. This test is especially valuable for individuals with a family history of breast cancer or those seeking to understand their genetic predisposition to the disease. By providing detailed genetic insights, the Breast Comprehensive Panel NGS Genetic Test empowers patients and healthcare providers to make informed decisions regarding prevention, surveillance, and management strategies for breast cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Breast Comprehensive Panel NGS Genetic Test

Cost: AED 4400.0

Test Name

Breast Comprehensive Panel NGS Genetic DNA Test

Components

Price: AED 4400.0

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Cancer

Doctor

Oncologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for Breast Comprehensive Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2

Test Details

Breast comprehensive panel NGS genetic DNA test is a type of genetic test that analyzes specific genes associated with breast cancer. This panel test uses next-generation sequencing (NGS) technology to examine multiple genes simultaneously, providing a more comprehensive analysis than traditional single-gene tests.

The breast comprehensive panel NGS genetic DNA test can identify mutations in genes such as BRCA1 and BRCA2, which are associated with an increased risk of developing breast and ovarian cancer. Other genes analyzed in this panel may include ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D.

This test is typically recommended for individuals with a personal or family history of breast cancer, particularly if there are multiple cases of breast or ovarian cancer in the family, early onset of breast cancer, or male breast cancer. The results of this test can help inform medical management decisions, such as increased surveillance or risk-reducing surgeries.

It is important to note that not all genetic mutations identified by this test are definitively associated with an increased risk of breast cancer, and the interpretation of test results should be done in consultation with a healthcare provider trained in genetics.

 

Test NameBreast comprehensive panel NGS Genetic DNA Test
Components 
Price4400.0 AED
Sample ConditionBlood or Extracted DNA or One drop Blood on FTA Card
Report Delivery3 to 4 Weeks
MethodNGS Technology
Test typeCancer
DoctorOncologist
Test Department:Genetics
Pre Test InformationClinical History of Patient who is going for Breast comprehensive panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2
Test Details

Breast comprehensive panel NGS genetic DNA test is a type of genetic test that analyzes specific genes associated with breast cancer. This panel test uses next-generation sequencing (NGS) technology to examine multiple genes simultaneously, providing a more comprehensive analysis than traditional single-gene tests.

The breast comprehensive panel NGS genetic DNA test can identify mutations in genes such as BRCA1 and BRCA2, which are associated with an increased risk of developing breast and ovarian cancer. Other genes analyzed in this panel may include ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D.

This test is typically recommended for individuals with a personal or family history of breast cancer, particularly if there are multiple cases of breast or ovarian cancer in the family, early onset of breast cancer, or male breast cancer. The results of this test can help inform medical management decisions, such as increased surveillance or risk-reducing surgeries.

It is important to note that not all genetic mutations identified by this test are definitively associated with an increased risk of breast cancer, and the interpretation of test results should be done in consultation with a healthcare provider trained in genetics.